Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant

Blinatumomab, a bispecific T‐cell engager monoclonal antibody used to manage Philadelphia chromosome‐negative relapsed or refractory B‐cell precursor acute lymphoblastic leukemia (ALL) can be used to treat patients by inducing graft versus leukemia reaction post allogeneic hematopoietic stem cell tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Waqas, Gul, Zartash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974418/
https://www.ncbi.nlm.nih.gov/pubmed/27525074
http://dx.doi.org/10.1002/ccr3.604
_version_ 1782446538840080384
author Khan, Muhammad Waqas
Gul, Zartash
author_facet Khan, Muhammad Waqas
Gul, Zartash
author_sort Khan, Muhammad Waqas
collection PubMed
description Blinatumomab, a bispecific T‐cell engager monoclonal antibody used to manage Philadelphia chromosome‐negative relapsed or refractory B‐cell precursor acute lymphoblastic leukemia (ALL) can be used to treat patients by inducing graft versus leukemia reaction post allogeneic hematopoietic stem cell transplantation, a feature which it was post allogeneic bone marrow transplantation, a feature which this drug was not aimed to do.
format Online
Article
Text
id pubmed-4974418
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49744182016-08-12 Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant Khan, Muhammad Waqas Gul, Zartash Clin Case Rep Case Reports Blinatumomab, a bispecific T‐cell engager monoclonal antibody used to manage Philadelphia chromosome‐negative relapsed or refractory B‐cell precursor acute lymphoblastic leukemia (ALL) can be used to treat patients by inducing graft versus leukemia reaction post allogeneic hematopoietic stem cell transplantation, a feature which it was post allogeneic bone marrow transplantation, a feature which this drug was not aimed to do. John Wiley and Sons Inc. 2016-06-24 /pmc/articles/PMC4974418/ /pubmed/27525074 http://dx.doi.org/10.1002/ccr3.604 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Khan, Muhammad Waqas
Gul, Zartash
Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title_full Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title_fullStr Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title_full_unstemmed Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title_short Blinatumomab may induce graft versus host leukemia in patients with pre‐B ALL relapsing after hematopoietic stem cell transplant
title_sort blinatumomab may induce graft versus host leukemia in patients with pre‐b all relapsing after hematopoietic stem cell transplant
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974418/
https://www.ncbi.nlm.nih.gov/pubmed/27525074
http://dx.doi.org/10.1002/ccr3.604
work_keys_str_mv AT khanmuhammadwaqas blinatumomabmayinducegraftversushostleukemiainpatientswithpreballrelapsingafterhematopoieticstemcelltransplant
AT gulzartash blinatumomabmayinducegraftversushostleukemiainpatientswithpreballrelapsingafterhematopoieticstemcelltransplant

Ejemplares similares